Ortivus is granted market approval of MobiMed in New Zealand.

Ortivus is now permitted to advertise and sell MobiMed in the New Zealand market.

We are happy to announce that all registration processes with the New Zealand Medical Device Authority, MedSafe are now completed. MobiMed is thereby notified on Medsafe’s Web Assisted Notification of Devices (WAND) database and Ortivus can now offer MobiMed to New Zealand’s prehospital care.

”Pre-hospital healthcare in New Zealand has many similarities with the UK, where we have been successful for many years. We are looking forward to working together with our partner, Trapeze to deliver sustainable solutions that will improve patient care outcomes.” Magnus Mårtensson, Chief Product Officer, Ortivus

About Ortivus

Ortivus develops and commercialises MobiMed, medical technology solutions for a safer and more efficient
healthcare. The company was founded in 1985 and is today a leading provider of mobile digital
solutions for prehospital care, worldwide. Ortivus' products are based on in-depth expertise
in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm and the company has, since 1998, a wholly-owned subsidiary based in the United Kingdom.

MobiMed is a modular platform that currently is used by over 12 000 paramedics in over 2 700 emergency vechicles. The platform consists of a monitor that in real-time measures, monitors and shares patients'
vital parameters, such as, ECG, blood pressure and blood oxygenation. The system also consists
of an electronic patient record for decision support, collection of patient data and clinical documentation.
MobiMed has a total weight of 2.5kg and is created to function in a demanding environment and out in
the field. The two-way communication supports telemedicine consulting with clinical experts while patient data is seamlessly integrated into the medical records at the hospitals and primary care centers. MobiMed saves time and helps healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.

Read more about Ortivus at www.ortivus.com

Ortivus is granted market approval of MobiMed in New Zealand.